Last Updated: November 8, 2026

Bpi Labs Company Profile

« Back to Dashboard


What is the competitive landscape for BPI LABS

BPI LABS has ten approved drugs.

There are two tentative approvals on BPI LABS drugs.

Summary for Bpi Labs
US Patents:0
Tradenames:10
Ingredients:10
NDAs:10
PTAB Cases with Bpi Labs as petitioner: See PTAB cases with Bpi Labs as petitioner

Drugs and US Patents for Bpi Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bpi Labs FLUORESCEIN SODIUM fluorescein sodium INJECTABLE;INTRAVENOUS 220046-001 Apr 30, 2026 AP RX No No ⤷  Start Trial ⤷  Start Trial
Bpi Labs NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 216977-001 Oct 6, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial
Bpi Labs ABLYSINOL dehydrated alcohol SOLUTION;INTRA-ARTERIAL 207987-001 Jun 21, 2018 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
Bpi Labs EPINEPHRINE epinephrine SOLUTION;INTRAVENOUS 205029-003 May 12, 2023 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
Bpi Labs TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 219478-001 Sep 3, 2026 AO RX No No ⤷  Start Trial ⤷  Start Trial
Bpi Labs ABLYSINOL dehydrated alcohol SOLUTION;INTRA-ARTERIAL 207987-002 Jun 21, 2018 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial
Bpi Labs ZOLEDRONIC ACID zoledronic acid INJECTABLE;INTRAVENOUS 207341-001 Dec 29, 2017 AP RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.